VC Firm a16z Raise $9 Billion Capital For Venture, Growth And Bio Funds

Leading VC powerhouse Andreessen Horowitz (a16z) announced that it has closed $9 billion in new capital for its venture capital, growth-stage and biotech-focused vehicles.

A leading venture capital firm and a prominent investor in the cryptocurrency space, Andreessen Horowitz, has raised a fresh $9 billion to further its involvement in the crypto industry, as part of venture, growth and bio funds.

a16z is amongst the leading venture capital companies investing in all sorts of crypto and tech-related projects, including Web3.

According to a recent announcement, the firm has raised 9$ billion “to invest via our Venture, Growth, and Bio Funds.”

Out of the total number, $1.5 billion will go to the Bio fund, $5 billion to the Growth Fund, and $2.5 billion to the Venture fund.

According to the announcement:

It is our role and mission to help these entrepreneurs build the best companies they can and achieve their important goals. With these new funds, including a $1.5B Bio fund, $5B Growth fund, and $2.5B Venture fund, coupled with the $2.2B Crypto Fund and $400M Seed Fund we raised in 2021, we will continue to invest across the entire spectrum of stages, writing checks as small as $25,000 and up to hundreds of millions of dollars.

The company has been historically bullish on the advent of cryptocurrencies. Its co-founder, Marc Andreessen, stated last year that Bitcoin is fundamental to the technological transformation.

a16z has been involved in multiple fundings in the industry. Last October, Axie Infinity raised $150 million in a funding round led by the VC firm.

It’s a capital arms race in the private markets, as enthusiasm for technology companies both traditional (software, etc.) and frontier (crypto, quantum computing, metaverse, etc.) remains red-hot. That the public markets are taking a slightly different tack in recent weeks doesn’t appear to have slowed the venture capital firm side of the fundraising coin.